Elvucitabine-13C,15N2

Elvucitabine-13C,15N2 is a chemical compound that is used in the field of medical research. Specifically, it is a labeled analogue of elvucitabine, which is a nucleoside reverse transcriptase inhibitor that has been studied for its potential as an anti-HIV drug. The labeling of Elvucitabine-13C,15N2 with carbon-13 and nitrogen-15 isotopes makes it useful for tracking the compound in biological systems, allowing researchers to gain a better understanding of how it is metabolized and distributed in the body. Chemically, Elvucitabine-13C,15N2 is a modified version of the naturally occurring nucleoside cytidine. It is comprised of a base molecule (cytosine) attached to a sugar molecule (2'-deoxyribose) and a phosphate group. The labeling of the compound with carbon-13 and nitrogen-15 isotopes does not significantly alter its chemical properties, but it does allow for more precise analysis using techniques such as nuclear magnetic resonance spectroscopy and mass spectrometry. Overall, Elvucitabine-13C,15N2 is a valuable tool for researchers studying the metabolism and distribution of elvucitabine, as well as for investigating the broader fields of nucleoside chemistry and medical research. Its unique labeling also makes it useful for applications such as drug development and pharmacokinetic studies.